Vanguard Asset Management »

Myriad Genetics shares owned by Vanguard Asset Management

Quarter-by-quarter ownership of Myriad Genetics (MYGN) shares owned by Vanguard Asset Management from 13F filings

Historical chart of Vanguard Asset Management investment in Myriad Genetics

Tip: Access up to 7 years of quarterly data

All positions including Myriad Genetics held by Vanguard Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Myriad Genetics by Vanguard Asset Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $253k 56k 4.50

More positions owned by Vanguard Asset Management

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Astrazeneca Ord (AZN)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
JPMorgan Chase & Co. (JPM)
Exxon Mobil Corporation (XOM)
Eli Lilly & Co. (LLY)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Johnson & Johnson (JNJ)

View all positions for Vanguard Asset Management

Top funds holding Myriad Genetics

OrbiMed Advisors
BlackRock
Vanguard Group
Millennium Management
State Street Corporation
Glenview Captal Management
D. E. Shaw & Co
Vanguard Capital Management
Morgan Stanley
Vanguard Portfolio Management
Goldman Sachs Group
Geode Capital Management
Acadian Asset Management
Jacobs Levy Equity Management
Federated Investors

View all funds holding Myriad Genetics